isoxazoles has been researched along with Koch's Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rubin, EJ | 1 |
| Alffenaar, JWC; Migliori, GB; Peloquin, CA | 1 |
| Martins Dos Santos, VAP; Rienksma, RA; Schaap, PJ; Suarez-Diez, M | 1 |
| Chandra Sekhar, KV; Naidu, KM; Raghavaiah, P; Sriram, D; Subbalakshmi, J; Suresh, A; Yogeeswari, P | 1 |
| Changtam, C; Hongmanee, P; Suksamrarn, A | 1 |
| Vora, A | 1 |
| Bugaenko, SE; Elistratova, NA; Maliev, BM; Mozhokina, GN; Sokolova, GB; Solov'eva, IP | 1 |
| FORTUNI, M; MERENDA, P; MORETTI, E; SEDIARI, F | 1 |
| Agrawal, S; Sharma, A | 1 |
9 other study(ies) available for isoxazoles and Koch's Disease
| Article | Year |
|---|---|
Reviving a Drug for Tuberculosis?
Topics: Animals; Antibiotics, Antitubercular; Drug Resistance, Bacterial; Ethionamide; Humans; Isoxazoles; Mice; Mycobacterium tuberculosis; Oxidoreductases; Prodrugs; Repressor Proteins; Spiro Compounds; Tuberculosis | 2017 |
Making optimal use of available anti-tuberculosis drugs: first steps to investigate terizidone.
Topics: Antitubercular Agents; Cycloserine; Humans; Isoxazoles; Oxazolidinones; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2018 |
Modeling Host-Pathogen Interaction to Elucidate the Metabolic Drug Response of Intracellular
Topics: Adenosine Triphosphatases; Amides; Amino Acids; Antitubercular Agents; Cycloserine; Diarylquinolines; Drug Tolerance; Ethambutol; Ethionamide; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Host-Pathogen Interactions; Humans; Isoniazid; Isoxazoles; Metabolic Networks and Pathways; Models, Biological; Mycobacterium bovis; Mycobacterium tuberculosis; Oxazolidinones; Spiro Compounds; Thiazines; Tuberculosis | 2019 |
Design, synthesis and antimycobacterial activity of various 3-(4-(substitutedsulfonyl)piperazin-1-yl)benzo[d]isoxazole derivatives.
Topics: Animals; Antitubercular Agents; Cell Proliferation; Cells, Cultured; Crystallography, X-Ray; Drug Design; Isoxazoles; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Piperazines; Structure-Activity Relationship; Tuberculosis | 2014 |
Isoxazole analogs of curcuminoids with highly potent multidrug-resistant antimycobacterial activity.
Topics: Antitubercular Agents; Curcuma; Curcumin; Humans; Isoxazoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis | 2010 |
Terizidone.
Topics: Antitubercular Agents; Humans; Isoxazoles; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2010 |
[Efficacy and tolerance of rezonizate in complex with fluoroquinolones or mycobutin on a model of experimental murine tuberculosis].
Topics: Animals; Antibiotics, Antitubercular; Disease Models, Animal; Drug Therapy, Combination; Drug Tolerance; Fluoroquinolones; Gatifloxacin; Isoxazoles; Levofloxacin; Mice; Mycobacterium tuberculosis; Ofloxacin; Oxazolidinones; Rifabutin; Tuberculosis | 2011 |
[EEG study of patients of chronic pulmonary tuberculosis during D-4-amino-3-isoxazolidone (cycloserine) therapy].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Cycloserine; Dermatologic Agents; Electroencephalography; Isoxazoles; Oxazolidinones; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
Dual mycobacterial infection in the setting of leflunomide treatment for rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mycobacterium leprae; Mycobacterium tuberculosis; Tuberculosis | 2007 |